Overview

Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects

Status:
Completed
Trial end date:
2018-01-16
Target enrollment:
Participant gender:
Summary
This will be a randomized, double blind, placebo controlled, 2 arm, parallel group, methodology study to assess the effect of 6 weeks of liraglutide administration on food intake in obese subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Liraglutide